I have excellent textbook content. Here is the full answer:
After sugammadex is given, free (unbound) sugammadex molecules remain in circulation. These can bind to any newly administered rocuronium, partially or fully neutralizing it before it reaches the neuromuscular junction. The magnitude of interference depends on how much free sugammadex remains, which is a function of how much time has passed.
-
Conservative guideline: Within 24 hours of sugammadex, the traditionally recommended approach is to use a benzylisoquinolinium (non-steroidal) NMBD like cisatracurium instead - because 24 hours represents the maximum clearance time for sugammadex.
-
Practical reality: Preclinical and clinical studies confirm rocuronium can be safely re-given as early as 5 minutes after sugammadex, provided you use a higher dose (1.2 mg/kg) and expect a slightly slower onset compared to a drug-naive patient.
-
Inverse relationship: The longer you wait after sugammadex, the faster the onset of the repeat rocuronium dose, and the longer its duration of block - because less free sugammadex is available to compete.
-
Re-reversal is possible: If rocuronium is re-given after sugammadex and you later need to reverse it again, sugammadex can still be used - but at much higher doses (8-20 mg/kg) to overcome the reduced free sugammadex-rocuronium binding capacity.
-
Avoid succinylcholine? No - succinylcholine is an entirely different mechanism (depolarizing, not steroidal), so sugammadex has no interaction with it. If the clinical situation permits, succinylcholine for RSI is unaffected by prior sugammadex.